€0.00
0.00%
Compare
BBiosenic SA vs UCB S.AUBBiosenic SA vs Argenx SEABBiosenic SA vs European MedicalEBBiosenic SA vs Celyad Oncology S.ACBBiosenic SA vs Financière de TubizeFBBiosenic SA vs BEL 20 | MarketB

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2014

Income Metrics

Revenue 0
Operating Income -1.9M
Net Income -1.9M

Balance Sheet Metrics

Total Assets 9.4M
Total Liabilities 29.8M
Shareholders Equity -20.4M

Cash Flow Metrics

Operating Cash Flow -3.2M
Free Cash Flow -260.0K

Revenue & Profitability Trend

Biosenic SA Income Statement From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Revenue i 0 0 0 1.0M 0
Cost of Goods Sold i - - - - -
Gross Profit i - - - - -
Gross Margin % i 0.0% 0.0% 0.0% 0.0% 0.0%
Operating Expenses
Research & Development i 3.9M 1.0M 619.0K 15.4M 7.5M
Selling, General & Administrative i 1.4M 693.0K 265.0K 1.8M 1.5M
Other Operating Expenses i 875.0K 272.0K 84.0K - -
Total Operating Expenses i 6.2M 2.0M 968.0K 17.2M 9.0M
Operating Income i -7.0M -2.3M -878.0K -15.0M -7.9M
Operating Margin % i 0.0% 0.0% 0.0% -1,501.7% 0.0%
Non-Operating Items
Interest Income i 57.0K 3.0K 0 24.0K 17.0K
Interest Expense i 1.5M 278.0K 62.0K 678.0K 261.0K
Other Non-Operating Income - - - - -
Pre-tax Income i -29.0M -3.0M -984.0K -15.8M -7.5M
Income Tax i -7.0K 0 0 78.0K 0
Effective Tax Rate % i 0.0% 0.0% 0.0% 0.0% 0.0%
Net Income i -29.0M -3.0M -984.0K -11.9M -10.3M
Net Margin % i 0.0% 0.0% 0.0% -1,194.0% 0.0%
Key Metrics
EBITDA i -8.0M -2.3M -909.0K -14.5M -6.2M
EPS (Basic) i €-0.21 €-0.02 €-14.89 €-1.02 €-1.08
EPS (Diluted) i €-0.21 €-0.02 €-14.89 €-1.02 €-1.08
Basic Shares Outstanding i 136932018 120132013 66389 11723182 9538538
Diluted Shares Outstanding i 136932018 120132013 66389 11723182 9538538

Income Statement Trend

Biosenic SA Balance Sheet From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Assets
Current Assets
Cash & Equivalents i 117.0K 1.8M 759.0K 14.6M 8.6M
Short-term Investments i - - 1.2M - -
Accounts Receivable i 153.0K 1.0M 0 1.1M 132.0K
Inventory i - - - - -
Other Current Assets 273.0K 290.0K 4.0K 328.0K 74.0K
Total Current Assets i 1.8M 4.6M 1.1M 18.8M 11.7M
Non-Current Assets
Property, Plant & Equipment i 56.0K 50.0K 13.0K 2.3M 3.4M
Goodwill i 3.0M 20.9M 0 28.0K 28.0K
Intangible Assets i 3.0M 17.3M 23.0K 28.0K 28.0K
Long-term Investments - - - - -
Other Non-Current Assets 137.0K 135.0K -13.0K 1.3M 1.0K
Total Non-Current Assets i 7.7M 24.7M 38.0K 6.0M 10.7M
Total Assets i 9.6M 29.3M 1.2M 24.8M 22.4M
Liabilities
Current Liabilities
Accounts Payable i 3.6M 2.0M 92.0K 5.2M 3.1M
Short-term Debt i 11.8M 8.0M 1.2M 3.1M 2.7M
Current Portion of Long-term Debt - - - - -
Other Current Liabilities 330.0K -2.0K -3.0K - -
Total Current Liabilities i 15.8M 10.4M 1.5M 9.8M 9.3M
Non-Current Liabilities
Long-term Debt i 16.3M 15.8M 2.3M 11.7M 11.0M
Deferred Tax Liabilities i - - - - -
Other Non-Current Liabilities - 68.0K 65.0K - 1.0K
Total Non-Current Liabilities i 16.4M 15.8M 2.3M 11.7M 11.0M
Total Liabilities i 32.3M 26.2M 3.8M 21.5M 20.3M
Equity
Common Stock i 6.3M 4.8M 664.0K 8.4M 5.5M
Retained Earnings i -34.9M -5.7M -7.2M -73.1M -61.6M
Treasury Stock i - - - - -
Other Equity - - - - -
Total Shareholders Equity i -22.7M 3.1M -2.7M 3.3M 2.0M
Key Metrics
Total Debt i 28.2M 23.8M 3.5M 14.8M 13.7M
Working Capital i -14.0M -5.7M -370.0K 9.0M 2.4M

Balance Sheet Composition

Biosenic SA Cash Flow Statement From 2019 to 2023

Metric 2023 2022 2021 2020 2019
Operating Activities
Net Income i -7.0M -2.3M -877.0K -17.4M -11.2M
Depreciation & Amortization i - - - - -
Stock-Based Compensation i - - -99.0K 266.0K -472.0K
Working Capital Changes i 55.0K 44.0K 10.0K -1.0M -5.0K
Operating Cash Flow i -7.0M -2.3M -958.0K -20.6M -14.2M
Investing Activities
Capital Expenditures i 6.0K -5.0K 0 -78.0K -289.0K
Acquisitions i 0 2.0M 0 12.0M 0
Investment Purchases i - - - - -
Investment Sales i - - - - -
Investing Cash Flow i 6.0K 2.0M 0 11.9M -289.0K
Financing Activities
Share Repurchases i - - - - -
Dividends Paid i - - - - -
Debt Issuance i 1.0M 1.0M 1.4M 10.3M 4.9M
Debt Repayment i -413.0K -424.0K -181.0K -6.6M -1.2M
Financing Cash Flow i 2.1M 1.1M 1.2M 12.3M 11.6M
Free Cash Flow i -3.5M -1.9M -1.1M -16.2M -10.7M
Net Change in Cash i -4.9M 778.0K 252.0K 3.6M -2.9M

Cash Flow Trend

Biosenic SA Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 0.00
Forward P/E -0.04
Price to Sales -0.60
PEG Ratio -0.04

Profitability Ratios

Profit Margin 0.00%
Operating Margin -70,700.00%
Return on Equity 126.75%
Return on Assets -46.20%

Financial Health

Current Ratio 0.53
Debt to Equity -1.15
Beta -1.67

Per Share Data

EPS (TTM) €-0.02
Book Value per Share €-0.04
Revenue per Share €-0.01

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
BIOS 1.6M 0.00 - 126.75% 0.00% -1.15
Argenx SE 41.4B 39.84 6.59 20.15% 30.50% 0.64
European Medical 20.7M 11.14 1.72 16.43% 3.46% 154.89
Celyad Oncology S.A 14.1M 15.75 5.83 56.33% 3,952.38% 0.00
Nippun Rana

Nippun Rana

Chasing the market trend!

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, an...

Financial data is updated regularly. All figures are in the company's reporting currency.